Toggle Main Menu Toggle Search

Open Access padlockePrints

Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing data sets

Lookup NU author(s): Professor Hanns Lochmuller, Professor Rita HorvathORCiD, Dr Ana TopfORCiD, Professor Volker StraubORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2024 American College of Medical Genetics and Genomics. Purpose: We set out to develop a publicly available tool that could accurately diagnose spinal muscular atrophy (SMA) in exome, genome, or panel sequencing data sets aligned to a GRCh37, GRCh38, or T2T reference genome. Methods: The SMA Finder algorithm detects the most common genetic causes of SMA by evaluating reads that overlap the c.840 position of the SMN1 and SMN2 paralogs. It uses these reads to determine whether an individual most likely has 0 functional copies of SMN1. Results: We developed SMA Finder and evaluated it on 16,626 exomes and 3911 genomes from the Broad Institute Center for Mendelian Genomics, 1157 exomes and 8762 panel samples from Tartu University Hospital, and 198,868 exomes and 198,868 genomes from the UK Biobank. SMA Finder's false-positive rate was below 1 in 200,000 samples, its positive predictive value was greater than 96%, and its true-positive rate was 29 out of 29. Most of these SMA diagnoses had initially been clinically misdiagnosed as limb-girdle muscular dystrophy. Conclusion: Our extensive evaluation of SMA Finder on exome, genome, and panel sequencing samples found it to have nearly 100% accuracy and demonstrated its ability to reduce diagnostic delays, particularly in individuals with milder subtypes of SMA. Given this accuracy, the common misdiagnoses identified here, the widespread availability of clinical confirmatory testing for SMA, and the existence of treatment options, we propose that it is time to add SMN1 to the American College of Medical Genetics list of genes with reportable secondary findings after genome and exome sequencing.


Publication metadata

Author(s): Weisburd B, Sharma R, Pata V, Reimand T, Ganesh VS, Austin-Tse C, Osei-Owusu I, O'Heir E, O'Leary M, Pais L, Stafki SA, Daugherty AL, Folland C, Peric S, Fahmy N, Udd B, Horakova M, Lusakowska A, Manoj R, Nalini A, Karcagi V, Polavarapu K, Lochmuller H, Horvath R, Bonnemann CG, Donkervoort S, Haliloglu G, Herguner O, Kang PB, Ravenscroft G, Laing N, Scott HS, Topf A, Straub V, Pajusalu S, Ounap K, Tiao G, Rehm HL, O'Donnell-Luria A

Publication type: Article

Publication status: Published

Journal: Genetics in Medicine

Year: 2025

Volume: 27

Issue: 4

Print publication date: 01/04/2025

Online publication date: 09/12/2024

Acceptance date: 02/12/2024

ISSN (print): 1098-3600

ISSN (electronic): 1530-0366

Publisher: Elsevier BV

URL: https://doi.org/10.1016/j.gim.2024.101336

DOI: 10.1016/j.gim.2024.101336

PubMed id: 39670433


Altmetrics

Altmetrics provided by Altmetric


Share

OSZAR »